CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 23 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,000 | -41.2% | 209,198 | +3.0% | 0.00% | – |
| Q2 2023 | $243,000 | -0.4% | 203,198 | -2.9% | 0.00% | -100.0% |
| Q1 2023 | $244,000 | +58.4% | 209,198 | +7.6% | 0.00% | – |
| Q4 2022 | $154,000 | -25.2% | 194,485 | +14.0% | 0.00% | -100.0% |
| Q3 2022 | $206,000 | +31.2% | 170,623 | 0.0% | 0.00% | – |
| Q2 2022 | $157,000 | -59.6% | 170,623 | -21.6% | 0.00% | -100.0% |
| Q1 2022 | $389,000 | +47.9% | 217,623 | +27.5% | 0.00% | 0.0% |
| Q4 2021 | $263,000 | -24.2% | 170,623 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $347,000 | -41.3% | 170,623 | +0.4% | 0.00% | -50.0% |
| Q2 2021 | $591,000 | +95.0% | 169,944 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $303,000 | +74.1% | 169,944 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $174,000 | – | 169,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 188,796 | $291,000 | 0.08% |
| Horst & Graben Wealth Management LLC | 75,722 | $117,000 | 0.03% |
| Alpine Global Management, LLC | 83,475 | $129,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $77,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,863 | $48,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 49,075 | $76,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $265,000 | 0.00% |
| Syverson Strege & Co | 2,145 | $3,000 | 0.00% |
| HighTower Advisors, LLC | 170,623 | $263,000 | 0.00% |
| HRT FINANCIAL LP | 90,871 | $139,000 | 0.00% |